NICE To Recruit Specialists To Advise On Assessment Of Breast Cancer Test
 

Recruitment is underway for five specialists to join NICE's Diagnostics Advisory Committee as it considers the clinical and cost effectiveness of a DNA based biochip assay which examines breast cancer tumour markers. Randox Breast Cancer Array (BCA) uses a biochip to analyse 23 genes simultaneously in order to define the clinical sub-groups of breast tumours...

More...